ously reported that expression of the transcription factor interferon regulatory factor 1 (IRF1) is an early, critical maladaptive signal expressed by renal tubules during murine ischemic acute kidney injury (AKI). We now show that IRF1 mediates signals from reactive oxygen species (ROS) generated during ischemic AKI and that these signals ultimately result in production of ␣-subtypes of type I interferons (IFN␣s). We found that genetic knockout of the common type I IFN receptor (IFNARI Ϫ/Ϫ ) improved kidney function and histology during AKI. There are major differences in the spatial-temporal production of the two major IFN subtypes, IFN and IFN␣s: IFN expression peaks at 4 h, earlier than IFN␣s, and continues at the same level at 24 h; expression of IFN␣s also increases at 4 h but continues to increase through 24 h. The magnitude of the increase in IFN␣s relative to baseline is much greater than that of IFN. We show by immunohistology and study of isolated cells that IFN is produced by renal leukocytes and IFN␣s are produced by renal tubules. IRF1, IFN␣s, and IFNARI were found on the same renal tubules during ischemic AKI. Furthermore, we found that ROS induced IFN␣ expression by renal tubules in vitro. This expression was inhibited by small interfering RNA knockdown of IRF1. Overexpression of IRF1 resulted in the production of IFN␣s. Furthermore, we found that IFN␣ stimulated production of maladaptive proinflammatory CXCL2 by renal tubular cells. Altogether our data support the following autocrine pathway in renal tubular cells:AKI; innate immunity; type I interferon ISCHEMIC ACUTE KIDNEY INJURY (AKI) causes significant shortterm morbidity and mortality (33) and, over the long-term, may contribute to the increasing incidence of end-stage renal disease (15,41,55). Despite these major clinical implications, there is currently no specific therapy beyond supportive care (33). A major insight into pathogenesis was the recognition that the initial ischemic insult elicits maladaptive responses that exacerbate the injury (31). In other words, the ultimate amount of renal injury is determined not only by the direct effects of hypoxia but also by the ensuing maladaptive responses. Understanding the latter may reveal novel therapeutic targets for the treatment of AKI.One maladaptive response is the production of type I interferons (IFNs). Knockout of the gene for the ␣-chain (IFNAR1) of the type I interferon (IFN) receptor heterodimer ameliorated ischemic AKI and decreased renal inflammation in mice (11). Such receptor knockout prevents signaling by, and thus the biological effects of, all type I IFNs (32, 37). These include IFN-, IFN-, IFNε, about which little is known, and also the better understood IFN and the IFN␣ family (which has 13 members in humans, 14 in mice).1 Their biological effects include increasing inflammation and increasing apoptosis (11). These effects should increase injury during ischemic AKI and are in addition to the more widely known antiviral effects of type I IFNs (36, 54).Despite their im...